Nature11 个月
End of the line for cannabinoid receptor 1 as an anti-obesity target?
A wave of terminations of development programmes for cannabinoid receptor 1 blockers for obesity indicates the demise of a drug class that was once anticipated to yield blockbusters. Nevertheless ...
Medscape29 天
Receptor for Advanced Glycation End Products: Its Role in Alzheimer's Disease and Other ...
Cite this: Receptor for Advanced Glycation End Products: Its Role in Alzheimer's Disease and Other Neurological Diseases - Medscape - Mar 31, 2009. Disclosure: The authors have no other relevant ...